Siga Technologies (SIGA) Shares Outstanding (2010 - 2025)
Siga Technologies' (SIGA) quarterly Shares Outstanding (Entity) came in at $71.6 million in Q4 2025, little changed on a YoY basis from $71.4 million in Q4 2024, and little changed quarter-over-quarter from $71.6 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Shares Outstanding (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Shares Outstanding (Entity) for 16 consecutive years, with $71.6 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Entity) changed 0.29% year-over-year to $71.6 million; the trailing twelve-month figure through Dec 2025 stood at $71.6 million (changed 0.29% YoY), and the FY2025 full-year result was $71.6 million, changed 0.29% from the prior year.
- Shares Outstanding (Entity) steadied at $71.6 million in Q4 2025 per SIGA's latest filing, from $71.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $76.2 million in Q1 2021 and bottomed at $71.1 million in Q2 2023.
- Historically, Shares Outstanding (Entity) has averaged $72.3 million across 5 years, with a median of $71.6 million in 2025.
- The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Entity) dropped 5.93% in 2021, then climbed 0.45% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $73.5 million in 2021, then dropped by 1.18% to $72.7 million in 2022, then fell by 2.18% to $71.1 million in 2023, then gained by 0.44% to $71.4 million in 2024, then gained by 0.29% to $71.6 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $71.6 million, $71.6 million, and $71.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 200.38 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 42.60 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 71.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 71.60 Mn |
| Sep 30, 2025 | 71.60 Mn |
| Jun 30, 2025 | 71.47 Mn |
| Mar 31, 2025 | 71.43 Mn |
| Dec 31, 2024 | 71.25 Mn |
| Sep 30, 2024 | 71.37 Mn |
| Jun 30, 2024 | 71.15 Mn |
| Mar 31, 2024 | 71.09 Mn |
| Dec 31, 2023 | 71.36 Mn |
| Sep 30, 2023 | 71.08 Mn |
| Jun 30, 2023 | 71.09 Mn |
| Mar 31, 2023 | 72.20 Mn |
| Dec 31, 2022 | 72.93 Mn |
| Sep 30, 2022 | 73.02 Mn |
| Jun 30, 2022 | 72.68 Mn |
| Mar 31, 2022 | 73.07 Mn |
| Dec 31, 2021 | 75.32 Mn |
| Sep 30, 2021 | 74.84 Mn |
| Jun 30, 2021 | 75.81 Mn |
| Mar 31, 2021 | 76.76 Mn |